Brief: AstraZeneca Secures Exclusive Global Rights to Selected Programs Under Insitro Collaboration
15/10/2026 11:38
BRIEF-AstraZeneca Secures Exclusive Global Rights to Selected Programs Under Insitro Collaboration Oct 15 (Reuters) - AstraZeneca PLC AZN.L:
ASTRAZENECA: GAINS EXCLUSIVE WORLDWIDE RIGHTS TO ADVANCE SELECTED PROGRAMMES UNDER COLLABORATION WITH INSITRO
Further company coverage: AZN.L
Recent news on AstraZeneca
See all newsAstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Early US flu season, current strain may signal risk for younger people; doctors urge shots
AstraZeneca partners with Oracle for AI-driven clinical trials
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Europe Research Roundup: Aumovio, Euronext, TotalEnergies